DGKα is up-regulated in hypofunctional OT-I T cells in B16 ovalbumin (OVA)-expressing tumors and therapeutic inhibition of DGKα combined with PD-1 blockade for improved tumor control (45). Here, DGKA is linked to neoplasm.